May 29th- Beyond the Webinar: Can We Finally Modify the Natural History of Myelofibrosis?

May 27th- CAR-T Before It’s Too Late: The New Myeloma Revolution

May 25th- Dr. Satoshi Yamasaki- GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study

May 21st- From Dysbiosis to Therapeutics: The New Era of Microbiota in Allo-HCT

May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma?

May 11th- Beyond the webinar: ISKIA and the New Era of MRD-Driven Myeloma Therapy: Are We Moving Closer to Cure?

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation